Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryophyllum pinnatum for Anxiety Symptoms
NCT04825171Phase 4Completed
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Bryophyllum pinnatum in anxiety disorder. Started Aug 2021; status: completed.
02
Drugs
Bryophyllum pinnatum
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04825171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04825171.